Sue Siegel has served as a CEO, VC, and Board Director. Sue has been recognized as Fortune’s “34 Leaders Who Are Changing Health Care,” as one of “The 100 Most Influential Women in Silicon Valley” and was awarded the “Lifetime Achievement Award” by Global Corporate Venture in 2020. She is an Aspen Institute Henry Crown Fellow and is a featured “Multiplier” in the bestselling book: “Multipliers: How the Best Leaders Make Everyone Smarter.”
Sue has served on 20 boards over the past 20+ years. Her Board portfolio includes Illumina (ILMN), Align (ALGN), Nevro (NVRO), the Kaiser Family Foundation, the UC Berkeley Bakar BioEnginuity Hub, and she is Chairman of MIT’s The Engine. Sue is a Lecturer on Entrepreneurship at MIT Sloan School of Management.
Sue drove the growth of Affymetrix. from a pre-revenue start-up to a multi-billion publicly-listed company that shaped the emerging genomics industry, including addressing the bioethical issues of its day. She served on President Obama’s Working Group for the Precision Medicine Initiative, was a founding board member of the NIH’s National Center for Advancing Translational Science, and served as a selection judge for White House Fellows across administrations.
Sue was GE’s Chief Innovation Officer, CEO of GE Ventures & Licensing, and CEO, Healthymagination. Prior to GE, she was a VC General Partner at Mohr Davidow Ventures, leading investments in Life Sciences & Health.